Location History:
- Helsinski, FI (1999)
- Helsinki, FI (2002 - 2022)
Company Filing History:
Years Active: 1999-2022
Title: The Innovations of Marc Henrik Baumann
Introduction
Marc Henrik Baumann is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of mass spectrometry and the study of amyloid-related diseases. With a total of 3 patents, his work focuses on innovative solutions for analyzing biological samples and addressing critical health issues.
Latest Patents
One of Baumann's latest patents is a sample holder for mass spectrometry analysis in MALDI mode. This invention describes a new type of sample holder designed for performing analyses of biological samples using mass spectrometry in MALDI mode. The patent outlines the process for producing the sample holder and provides protocols for its use in this technique. The sample holder consists of a support with at least one porous deposit made of nanoparticles of a Group 4 metal oxide.
Another significant patent involves peptides and pharmaceutical compositions aimed at treating disorders associated with abnormal protein folding into amyloid or amyloid-like deposits. This innovation introduces novel peptides that can interact with a hydrophobic β-sheet forming cluster of amino acid residues on proteins or peptides. These peptides inhibit and structurally block the abnormal folding of proteins into amyloid or amyloid-like deposits, which are precursors to diseases such as Alzheimer's and prion-related encephalopathies.
Career Highlights
Throughout his career, Marc Henrik Baumann has worked with prestigious institutions, including New York University and Tethis S.p.a. His research has significantly advanced the understanding of mass spectrometry and its applications in biological analysis.
Collaborations
Baumann has collaborated with notable individuals in his field, including Claudio Soto-Jara and Blas Frangione. These partnerships have contributed to the development of his innovative patents and research.
Conclusion
Marc Henrik Baumann's contributions to the fields of mass spectrometry and amyloid-related diseases highlight his role as a leading inventor. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and improving health outcomes.